• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapy.

作者信息

Potter W R, Henderson B W, Bellnier D A, Pandey R K, Vaughan L A, Weishaupt K R, Dougherty T J

机构信息

Roswell Park Cancer Institute, PDT Center, Buffalo, NY, USA.

出版信息

Photochem Photobiol. 1999 Nov;70(5):781-8.

PMID:10568170
Abstract

An open three-compartment pharmacokinetic model was applied to the in vivo quantitative structure-activity relationship (QSAR) data of a homologous series of pyropheophorbide photosensitizers for photodynamic therapy (PDT). The physical model was a lipid compartment sandwiched between two identical aqueous compartments. The first compartment was assumed to clear irreversibly at a rate K0. The measured octanol-water partition coefficients, P(i) (where i is the number of carbons in the alkyl chain) and the clearance rate K0 determined the clearance kinetics of the drugs. Solving the coupled differential equations of the three-compartment model produced clearance kinetics for each of the sensitizers in each of the compartments. The third compartment was found to contain the target of PDT. This series of compounds is quite lipophilic. Therefore these drugs are found mainly in the second compartment. The drug level in the third compartment represents a small fraction of the tissue level and is thus not accessible to direct measurement by extraction. The second compartment of the model accurately predicted the clearance from the serum of mice of the hexyl ether of pyropheophorbide a, one member of this series of compounds. The diffusion and clearance rate constants were those found by fitting the pharmacokinetics of the third compartment to the QSAR data. This result validated the magnitude and mechanistic significance of the rate constants used to model the QSAR data. The PDT response to dose theory was applied to the kinetic behavior of the target compartment drug concentration. This produced a pharmacokinetic-based function connecting PDT response to dose as a function of time postinjection. This mechanistic dose-response function was fitted to published, single time point QSAR data for the pheophorbides. As a result, the PDT target threshold dose together with the predicted QSAR as a function of time postinjection was found.

摘要

相似文献

1
Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapy.
Photochem Photobiol. 1999 Nov;70(5):781-8.
2
An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy.焦脱镁叶绿酸衍生物同系物作为光动力疗法光敏剂的体内定量构效关系
Cancer Res. 1997 Sep 15;57(18):4000-7.
3
Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide-a derivatives.焦脱镁叶绿酸-a衍生物的亚细胞定位模式及其与光动力活性的关系。
Photochem Photobiol. 1999 Nov;70(5):789-97.
4
Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.光动力治疗药物2-[1-己氧基乙基]-2-去乙烯基焦脱镁叶绿酸-a在癌症患者中的群体药代动力学
Cancer Res. 2003 Apr 15;63(8):1806-13.
5
Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.在人肿瘤异种移植模型中,使用低剂量的卟啉钠可增强5-氨基酮戊酸介导的光动力疗法的抗肿瘤效果。
Cancer Res. 2001 Aug 1;61(15):5824-32.
6
Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible "see and treat" approach.用于肿瘤成像(PET、荧光)和光动力治疗的多模态制剂。一种可能的“可视即治疗”方法。
J Med Chem. 2005 Oct 6;48(20):6286-95. doi: 10.1021/jm050427m.
7
Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX.光动力疗法光敏剂卟吩姆钠(Photofrin)、2-[1-己氧基乙基]-2-去乙烯基焦脱镁叶绿酸-a(Photochlor)以及5-氨基酮戊酸诱导产生的原卟啉IX的临床药代动力学。
Lasers Surg Med. 2006 Jun;38(5):439-44. doi: 10.1002/lsm.20340.
8
Structure-activity relationships of mono-substituted trisulfonated porphyrazines for the photodynamic therapy (PDT) of cancer.单取代三磺化卟啉类化合物用于癌症光动力疗法(PDT)的构效关系。
Photochem Photobiol Sci. 2010 Mar;9(3):331-41. doi: 10.1039/b9pp00109c. Epub 2010 Jan 27.
9
Synthesis and biological evaluation of 17-dicarboxylethyl-pyropheophorbide-a amide derivatives for photodynamic therapy.用于光动力治疗的17-二羧酸乙酯-焦脱镁叶绿酸-a酰胺衍生物的合成及生物学评价
Bioorg Med Chem Lett. 2018 Sep 1;28(16):2784-2788. doi: 10.1016/j.bmcl.2017.12.034. Epub 2017 Dec 19.
10
Photosensitizers derived from 132-oxo-methyl pyropheophorbide-a: enhanced effect of indium(III) as a central metal in in vitro and in vivo photosensitizing efficacy.
Photochem Photobiol. 2006 May-Jun;82(3):626-34. doi: 10.1562/2005-09-29-RA-704.

引用本文的文献

1
Application of TD-DFT Theory to Studying Porphyrinoid-Based Photosensitizers for Photodynamic Therapy: A Review.应用 TD-DFT 理论研究卟啉类光动力治疗剂:综述。
Molecules. 2021 Nov 26;26(23):7176. doi: 10.3390/molecules26237176.
2
Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.光动力疗法的机制:第一部分——光敏剂、光化学和细胞定位。
Photodiagnosis Photodyn Ther. 2004 Dec;1(4):279-93. doi: 10.1016/S1572-1000(05)00007-4.
3
Validation of quantitative structure-activity relationship (QSAR) model for photosensitizer activity prediction.
用于预测光敏剂活性的定量构效关系(QSAR)模型的验证
Int J Mol Sci. 2011;12(12):8626-44. doi: 10.3390/ijms12128626. Epub 2011 Nov 29.
4
Like a bolt from the blue: phthalocyanines in biomedical optics.犹如晴天霹雳:酞菁在生物医学光学中的应用。
Molecules. 2011 Dec 23;17(1):98-144. doi: 10.3390/molecules17010098.
5
Substrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy.叶绿素-a 衍生的光敏剂的底物亲和力:ABCG2 转运蛋白影响侧群干细胞样癌细胞对光动力疗法的光毒性反应。
Mol Pharm. 2010 Oct 4;7(5):1789-804. doi: 10.1021/mp100154j. Epub 2010 Sep 1.
6
Conjugation of 2-(1'-hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivo.2-(1'-己氧基乙基)-2-去乙烯基焦脱镁叶绿酸-a(HPPH)与碳水化合物的共轭作用改变了其亚细胞分布,并增强了体内的光动力活性。
J Med Chem. 2009 Jul 23;52(14):4306-18. doi: 10.1021/jm9001617.
7
Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism.功能化富勒烯介导的癌细胞光动力杀伤:I型与II型光化学机制
Free Radic Biol Med. 2007 Sep 1;43(5):711-9. doi: 10.1016/j.freeradbiomed.2007.05.005. Epub 2007 May 10.